Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
India’s deteriorating air quality has triggered a sharp rise in respiratory medicine consumption, with sales of asthma, COPD, and allergy drugs spiking strongly in November. Hospital data and pharmacy trends indicate that urban pollution levels have directly translated into increased prescriptions for bronchodilators, inhaled steroids, and anti-allergy treatments, particularly in major metro regions. Industry executives report that acute pollution episodes are now acting as short-term demand accelerators, reshaping seasonal forecasting models for respiratory drug manufacturers. The trend highlights how climate and environmental stressors are becoming structural growth drivers for chronic respiratory therapies, even as public-health costs continue to mount.
You May Interested In
2026-09-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
U.S. Includes Lithium in National Defense Stockpile for First Time, Plans to Purchase 16,200 Tons Over Five Years
-
COIM Group Expands Alkyd and Acrylic Resin Production Capacity in the Netherlands
-
Canada’s Acynonapyr Review Offers More Than a New Mite Product
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
-
India’s Latest Manufacturing Clarification Is Really a Delayed Regulatory Line in the Sand
-
Global Ag M&A in 2025 Looked Less Like Expansion and More Like Selection
-
South Korea Tests Arctic Commercial Route as Asian Exporters Seek New Logistics Alternatives
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
South Africa Wants Lenacapavir at Home, Not Just Imported
Recommend Reading
-
![Redwall Raises Prices by as Much as 80%, Songwon Launches Global Increases, and Chemical Companies Are Collectively Passing On Costs]()
Redwall Raises Prices by as Much as 80%, Songwon Launches Global Increases, and Chemical Companies Are Collectively Passing On Costs
-
![Can Lotte Chemical's Four Growth Pillars Support Its New Valuation After Spinning Off Basic Chemicals?]()
Can Lotte Chemical's Four Growth Pillars Support Its New Valuation After Spinning Off Basic Chemicals?
-
![Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik]()
Rhine Drought Disrupts German Chemical Logistics, Raising Supply Risks for BASF, Covestro and Evonik
-
![Middle East Conflict Pushes Up Oil Prices as More Than 100 Chemical Raw Materials Rise in Concentration]()
Middle East Conflict Pushes Up Oil Prices as More Than 100 Chemical Raw Materials Rise in Concentration
-
![Global Trade Data for Epoxy Resin in 2025 Released: Asia Accounted for $640 Million in Imports, Vietnam Emerges as Top Buyer]()
Global Trade Data for Epoxy Resin in 2025 Released: Asia Accounted for $640 Million in Imports, Vietnam Emerges as Top Buyer
-
![Business Society’s Market Outlook for Phthalic Anhydride on August 24, 2026: Deep Correction with a Bearish Bias]()
Business Society’s Market Outlook for Phthalic Anhydride on August 24, 2026: Deep Correction with a Bearish Bias
-
![Cost Benefits Provide Support, Boosting PTA Prices]()
Cost Benefits Provide Support, Boosting PTA Prices
-
![Cost Values and Demand-Side Game: PP Prices Consolidate After Rising in July]()
Cost Values and Demand-Side Game: PP Prices Consolidate After Rising in July
-
![Coke Market Stably Strong, Price Increase Implemented at Midnight on the 26th]()
Coke Market Stably Strong, Price Increase Implemented at Midnight on the 26th
-
![Oxalic Acid: Acidity (pKa), Sources, and Kidney Stone Risk]()
Oxalic Acid: Acidity (pKa), Sources, and Kidney Stone Risk
